Idiopathic Intracranial Hypertension: Diagnosis & Clinical Features
Idiopathic intracranial hypertension (IIH) is a condition of elevated intracranial pressure (ICP) of unknown etiology, occurring most commonly in young women with obesity. Previously termed pseudotumor cerebri or benign intracranial hypertension, IIH is increasingly recognized as a systemic metabolic disorder associated with significant morbidity, including progressive and potentially permanent vision loss. The incidence has risen in parallel with the obesity epidemic, making it a condition of growing importance in neurologic practice. Accurate diagnosis requires careful application of the modified Dandy criteria, thorough ophthalmologic evaluation, and systematic exclusion of secondary causes.
Bottom Line
- Epidemiology: Incidence ~1.97/100,000 in women; rising in parallel with obesity rates; F:M ratio 8:1 in reproductive years
- Hallmark: Papilledema is the hallmark sign — present in the vast majority; a small subset has IIH without papilledema
- Visual symptoms: Transient visual obscurations (TWO), visual field defects (enlarged blind spot, nasal step), and sixth nerve palsy
- Headache: Present in 78–95% but lacks distinctive features; phenotype most commonly resembles migraine
- Modified Dandy criteria: Papilledema + normal neurologic examination (except VI nerve) + normal neuroimaging + elevated CSF opening pressure (>25 cm H2O) + normal CSF composition
- MRI features: Empty or partially empty sella, flattening of the posterior globe, distension of perioptic subarachnoid space, transverse sinus stenosis
- Diagnostic pitfalls: Overdiagnosis occurs in ~40% of referrals; ophthalmoscopy must be performed; isolated MRI features are not diagnostic
Epidemiology
| Parameter | Data |
|---|---|
| Overall incidence | 0.9–1.97 per 100,000 per year |
| Women of reproductive age | 3.5–19 per 100,000 per year (rising with increasing BMI) |
| Men | ~0.5 per 100,000 per year |
| Children | 0.5–0.7 per 100,000; prepubertal cases show equal sex distribution |
| Sex ratio (adults) | F:M approximately 8:1 |
| BMI association | Risk increases exponentially above BMI 30 kg/m² |
| Racial disparities | Higher prevalence in Black women in the United States |
| Trend | Incidence increasing, mirroring rising obesity rates globally |
Risk Factors and Associations
- Obesity: The primary modifiable risk factor; IIH is increasingly viewed as a systemic metabolic disorder
- Weight gain: Even 5–15% weight gain carries risk for both developing and recurring IIH
- Obstructive sleep apnea: Potential contributor to worse visual outcomes; consider screening in patients who do not fit the typical demographic
- Polycystic ovarian syndrome: 1.5-fold increased risk; phenotypically similar hyperandrogenic disorder
- Cardiovascular risk: IIH associated with increased risk of cardiovascular events in women
- Mental health: Depression, anxiety frequently coexist and may worsen outcomes; suicide risk is more than 6 times higher than in the general population
Modified Dandy Criteria
Diagnostic Criteria for IIH
- Signs and symptoms of elevated ICP: Papilledema, headache, pulsatile tinnitus, transient visual obscurations, diplopia from sixth nerve palsy
- Normal neurologic examination except for papilledema, sixth nerve palsy, or visual field defect
- Neuroimaging: No evidence of hydrocephalus, mass lesion, structural cause, or abnormal meningeal enhancement on MRI with contrast and MR or CT venography
- Elevated CSF opening pressure: >25 cm H2O in adults, >28 cm H2O in children (measured in the lateral decubitus position, legs extended, patient relaxed)
- Normal CSF composition: Normal cell count, glucose, and protein
Clinical Features
Papilledema
Papilledema — bilateral optic disc swelling caused by elevated ICP transmitted along the optic nerve sheath — is the hallmark sign of IIH and the primary determinant of treatment urgency.
| Frisén Grade | Description | Clinical Significance |
|---|---|---|
| Grade 0 | Normal optic disc | No papilledema |
| Grade 1 | C-shaped halo of disc edema; obscuration of nasal disc border | Mild; may be subtle and difficult to distinguish from pseudopapilledema |
| Grade 2 | Circumferential halo of disc edema; obscuration of all disc margins | Moderate; visual function usually preserved |
| Grade 3 | Obscuration of one or more major retinal vessels leaving the disc | Moderate to severe; monitor closely for visual deterioration |
| Grade 4 | Obscuration of all major vessels on the disc; possible retinal folds | Severe; visual function at risk; consider escalation of treatment |
| Grade 5 | Total obscuration of disc; dome-shaped protrusion; retinal vessel obscuration extends beyond disc margin | Very severe; vision-threatening; urgent intervention required |
Critical Points About Papilledema
- Papilledema can be asymmetric — unilateral or significantly different between eyes
- Some patients are asymptomatic with papilledema discovered incidentally on routine eye examination
- Headache frequency and severity do not correlate with papilledema severity — patients with minimal headache can have severe papilledema
- Rapidly declining visual acuity suggests severe optic nerve ischemia and requires urgent evaluation
- Acquired dyschromatopsia (abnormal color vision) in the setting of papilledema is a serious sign indicating threatening optic neuropathy
Visual Symptoms
| Symptom | Description | Frequency |
|---|---|---|
| Transient visual obscurations | Brief (seconds) episodes of monocular or binocular visual dimming or graying; often triggered by positional change | ~68% |
| Visual field loss | Enlargement of blind spot (earliest), nasal step, arcuate defects, generalized constriction (late) | Progressive; may be asymptomatic until advanced |
| Diplopia | Horizontal binocular diplopia from unilateral or bilateral sixth (abducens) nerve palsy; false localizing sign | ~20–30% |
| Blurred vision | May reflect papilledema-related hypermetropic shift or incipient visual field loss | Common |
| Photopsia | Flashes of light; less common than in retinal disease | Occasional |
Headache
- Present in 78–95% of IIH patients
- The headache phenotype most commonly resembles migraine (52% in the IIHTT), followed by tension-type (22%) and probable migraine (16%)
- Headache lacks distinctive features that reliably distinguish it from primary headache disorders
- IIH patients are 6 times more likely to develop migraine than the general population
- A potential differentiator: headaches associated with elevated ICP are often worse on awakening and may worsen with Valsalva
- Headache severity does not correlate with opening pressure, papilledema grade, or visual function
Other Symptoms
- Pulsatile tinnitus: Rhythmic whooshing sound synchronous with the heartbeat; present in ~52–60%; may be the presenting complaint
- Neuro-otologic symptoms: Hearing loss, dizziness, aural fullness
- Cognitive symptoms: Difficulty concentrating, brain fog, reduced processing speed; reversible with treatment
- Neck and back pain: Radicular symptoms can occur from nerve root sleeve distension
Diagnostic Investigations
Ophthalmologic Assessment
Essential Visual Monitoring
- Visual acuity: High-contrast best-corrected visual acuity at 6 meters; recheck with pinhole; declining acuity is a serious sign
- Color vision: Pseudoisochromatic plates; abnormal color vision indicates optic nerve dysfunction
- Pupil examination: Relative afferent pupillary defect indicates asymmetric optic nerve damage
- Visual field testing: Automated perimetry (Humphrey 24-2) at every visit; most sensitive measure of visual function in papilledema
- Fundoscopy: Dilated examination to grade papilledema (Frisén scale); fundus photography for documentation
- OCT (optical coherence tomography): Peripapillary retinal nerve fiber layer thickness — the most sensitive objective measure for monitoring papilledema change over time
Neuroimaging
| MRI Finding | Description | Sensitivity/Specificity |
|---|---|---|
| Empty or partially empty sella | Flattened pituitary gland from CSF pressure on the diaphragma sellae | Moderate sensitivity; not specific |
| Flattening of the posterior globe | Inward bowing of the posterior sclera from elevated optic nerve sheath pressure | High specificity |
| Perioptic subarachnoid space distension | CSF distension of the optic nerve sheath; tortuous optic nerve | Moderate; more common with higher ICP |
| Transverse sinus stenosis | Bilateral narrowing at the transverse-sigmoid junction on MR or CT venography | Present in >90% of IIH patients; also common in the general population |
| Optic nerve head protrusion | Protrusion of the optic disc into the vitreous | Correlates with papilledema grade |
Neuroimaging Pitfalls
- A combination of ≥3 MRI features is ~100% specific and ~64% sensitive for identifying papilledema in IIH patients
- MRI features alone, without clinical confirmation of papilledema or sixth nerve palsy, are not diagnostic of IIH
- Incidental MRI findings associated with IIH are common in the general population (especially transverse sinus stenosis and empty sella) and should not trigger a diagnosis without papilledema
- Treatment trials for IIH did not include patients with IIH without papilledema
Lumbar Puncture
- Position: Lateral decubitus, legs extended, patient relaxed, head in neutral position
- Elevated opening pressure: >25 cm H2O for adults; >28 cm H2O for children
- Sedation caution: In children, sedation may cause hypercapnia and falsely elevate CSF pressure
- Normal CSF: Cell count, glucose, and protein must be normal for IIH diagnosis
- Note: Opening pressure does not correlate with disease activity, visual loss, or need for emergency management — treatment decisions should be guided by visual function
MR/CT Venography
- Required to exclude cerebral venous sinus thrombosis as a secondary cause of elevated ICP
- Bilateral transverse sinus stenosis is common in IIH but is usually extrinsic compression from elevated ICP (not thrombotic)
- Venous sinus stenosis may play a pathogenic role in some patients and is a target for stenting in refractory cases
IIH Without Papilledema
A diagnosis of IIH can be suggested in the absence of papilledema or sixth nerve palsy if:
- All other modified Dandy criteria are met
- At least 3 typical MRI features are present (empty sella, posterior globe flattening, perioptic subarachnoid space distension, transverse venous sinus stenosis)
- Elevated opening pressure is documented (≥25 cm H2O)
IIH Without Papilledema: Key Points
- Patients typically have chronic headaches with elevated ICP but no visual loss
- It is unclear whether this represents a distinct entity or early IIH before papilledema develops
- These patients should be monitored longitudinally for possible delayed papilledema development
- Treatment trials (IIHTT) did not include this population
- Overdiagnosis is a risk — isolated MRI features plus headache do not establish the diagnosis
Diagnostic Errors
A retrospective study of 165 patients referred to a neuro-ophthalmology clinic with a diagnosis of IIH found that overdiagnosis had occurred in 39.5%:
- Underuse of diagnostic tests: Failure to perform ophthalmoscopy or OCT; not performing visual fields
- Overuse of diagnostic tests: Relying on isolated MRI findings (e.g., empty sella or transverse sinus stenosis) without confirming papilledema
- Anchoring bias: Assuming obese women with headache have IIH without proper diagnostic workup
- Consequences: Unnecessary medications (acetazolamide side effects), invasive procedures, and missed alternative diagnoses
Differential Diagnosis
| Condition | Key Distinguishing Features |
|---|---|
| Cerebral venous sinus thrombosis | Filling defect on venography; may have focal neurologic signs; fever, hypercoagulable state |
| Intracranial mass lesion | Focal neurologic signs; mass on MRI; may have papilledema |
| Meningitis (infectious or neoplastic) | Abnormal CSF composition (pleocytosis, elevated protein, low glucose); meningeal enhancement on MRI |
| Medication-induced intracranial hypertension | Tetracyclines (minocycline, doxycycline), vitamin A/retinoids, growth hormone; resolves with discontinuation |
| MOGAD with bilateral optic disc edema | Can mimic fulminant IIH; up to 21% have elevated opening pressure; MRI orbits with contrast recommended |
| Pseudopapilledema | Optic disc drusen; elevated disc without true swelling; OCT and autofluorescence can differentiate |
| Obstructive hydrocephalus | Ventricular enlargement on imaging; different mechanism of elevated ICP |
References
- Antonio LB. Clinical features and diagnosis of idiopathic intracranial hypertension. Continuum (Minneap Minn). 2025;31(3):709-727.
- Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165.
- NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss. JAMA. 2014;311(16):1641-1651.
- Mollan SP, Aguiar M, Evison F, et al. The expanding burden of idiopathic intracranial hypertension. Eye (Lond). 2019;33(3):478-485.
- Fisayo A, Bruce BB, Newman NJ, Biousse V. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016;86(4):341-350.